nodes	percent_of_prediction	percent_of_DWPC	metapath
Aclidinium—BCHE—multiple sclerosis	0.802	1	CbGaD
Aclidinium—BCHE—Triamcinolone—multiple sclerosis	0.0803	1	CbGbCtD
Aclidinium—Atrioventricular block first degree—Fingolimod—multiple sclerosis	0.0101	0.117	CcSEcCtD
Aclidinium—Infestation NOS—Fingolimod—multiple sclerosis	0.00214	0.0249	CcSEcCtD
Aclidinium—Infestation—Fingolimod—multiple sclerosis	0.00214	0.0249	CcSEcCtD
Aclidinium—Sinusitis—Fingolimod—multiple sclerosis	0.00201	0.0234	CcSEcCtD
Aclidinium—Eye disorder—Fingolimod—multiple sclerosis	0.0018	0.0209	CcSEcCtD
Aclidinium—Mediastinal disorder—Fingolimod—multiple sclerosis	0.00174	0.0202	CcSEcCtD
Aclidinium—Cardiac failure—Cladribine—multiple sclerosis	0.00162	0.0188	CcSEcCtD
Aclidinium—Vision blurred—Fingolimod—multiple sclerosis	0.00158	0.0184	CcSEcCtD
Aclidinium—Cough—Fingolimod—multiple sclerosis	0.00146	0.017	CcSEcCtD
Aclidinium—Infection—Fingolimod—multiple sclerosis	0.00136	0.0158	CcSEcCtD
Aclidinium—Nervous system disorder—Fingolimod—multiple sclerosis	0.00134	0.0156	CcSEcCtD
Aclidinium—Infestation NOS—Cladribine—multiple sclerosis	0.00122	0.0141	CcSEcCtD
Aclidinium—Infestation—Cladribine—multiple sclerosis	0.00122	0.0141	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Fingolimod—multiple sclerosis	0.00118	0.0137	CcSEcCtD
Aclidinium—Urinary tract disorder—Cladribine—multiple sclerosis	0.00108	0.0125	CcSEcCtD
Aclidinium—Urethral disorder—Cladribine—multiple sclerosis	0.00107	0.0124	CcSEcCtD
Aclidinium—Cardiac failure—Mitoxantrone—multiple sclerosis	0.00106	0.0124	CcSEcCtD
Aclidinium—Eye disorder—Cladribine—multiple sclerosis	0.00102	0.0119	CcSEcCtD
Aclidinium—Infestation NOS—Azathioprine—multiple sclerosis	0.000989	0.0115	CcSEcCtD
Aclidinium—Infestation—Azathioprine—multiple sclerosis	0.000989	0.0115	CcSEcCtD
Aclidinium—Mediastinal disorder—Cladribine—multiple sclerosis	0.000984	0.0114	CcSEcCtD
Aclidinium—Diabetes mellitus—Prednisolone—multiple sclerosis	0.000978	0.0114	CcSEcCtD
Aclidinium—Diarrhoea—Fingolimod—multiple sclerosis	0.000936	0.0109	CcSEcCtD
Aclidinium—Diabetes mellitus—Triamcinolone—multiple sclerosis	0.0009	0.0105	CcSEcCtD
Aclidinium—Diabetes mellitus—Methylprednisolone—multiple sclerosis	0.000898	0.0104	CcSEcCtD
Aclidinium—Headache—Fingolimod—multiple sclerosis	0.000857	0.00996	CcSEcCtD
Aclidinium—Osteoarthritis—Prednisolone—multiple sclerosis	0.000851	0.00989	CcSEcCtD
Aclidinium—Cough—Cladribine—multiple sclerosis	0.000829	0.00964	CcSEcCtD
Aclidinium—Diabetes mellitus—Dexamethasone—multiple sclerosis	0.000816	0.00949	CcSEcCtD
Aclidinium—Diabetes mellitus—Betamethasone—multiple sclerosis	0.000816	0.00949	CcSEcCtD
Aclidinium—Cardiac failure—Methylprednisolone—multiple sclerosis	0.0008	0.0093	CcSEcCtD
Aclidinium—Mediastinal disorder—Azathioprine—multiple sclerosis	0.0008	0.0093	CcSEcCtD
Aclidinium—Osteoarthritis—Triamcinolone—multiple sclerosis	0.000782	0.0091	CcSEcCtD
Aclidinium—Osteoarthritis—Methylprednisolone—multiple sclerosis	0.000781	0.00908	CcSEcCtD
Aclidinium—Infection—Cladribine—multiple sclerosis	0.00077	0.00896	CcSEcCtD
Aclidinium—Nervous system disorder—Cladribine—multiple sclerosis	0.00076	0.00884	CcSEcCtD
Aclidinium—Tachycardia—Cladribine—multiple sclerosis	0.000757	0.0088	CcSEcCtD
Aclidinium—Sinusitis—Mitoxantrone—multiple sclerosis	0.00075	0.00872	CcSEcCtD
Aclidinium—Cardiac failure—Dexamethasone—multiple sclerosis	0.000727	0.00846	CcSEcCtD
Aclidinium—Cardiac failure—Betamethasone—multiple sclerosis	0.000727	0.00846	CcSEcCtD
Aclidinium—Rhinitis—Mitoxantrone—multiple sclerosis	0.000719	0.00836	CcSEcCtD
Aclidinium—Diabetes mellitus—Prednisone—multiple sclerosis	0.000711	0.00826	CcSEcCtD
Aclidinium—Osteoarthritis—Dexamethasone—multiple sclerosis	0.00071	0.00825	CcSEcCtD
Aclidinium—Osteoarthritis—Betamethasone—multiple sclerosis	0.00071	0.00825	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.000669	0.00778	CcSEcCtD
Aclidinium—Cardiac failure—Prednisone—multiple sclerosis	0.000634	0.00737	CcSEcCtD
Aclidinium—Infection—Azathioprine—multiple sclerosis	0.000626	0.00728	CcSEcCtD
Aclidinium—Osteoarthritis—Prednisone—multiple sclerosis	0.000618	0.00719	CcSEcCtD
Aclidinium—Infestation NOS—Methylprednisolone—multiple sclerosis	0.000602	0.00699	CcSEcCtD
Aclidinium—Infestation—Methylprednisolone—multiple sclerosis	0.000602	0.00699	CcSEcCtD
Aclidinium—Diabetes mellitus—Methotrexate—multiple sclerosis	0.000594	0.00691	CcSEcCtD
Aclidinium—Vision blurred—Mitoxantrone—multiple sclerosis	0.000589	0.00684	CcSEcCtD
Aclidinium—Cough—Mitoxantrone—multiple sclerosis	0.000545	0.00634	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000544	0.00633	CcSEcCtD
Aclidinium—Rhinitis—Triamcinolone—multiple sclerosis	0.000543	0.00631	CcSEcCtD
Aclidinium—Rhinitis—Methylprednisolone—multiple sclerosis	0.000541	0.0063	CcSEcCtD
Aclidinium—Diarrhoea—Cladribine—multiple sclerosis	0.000531	0.00617	CcSEcCtD
Aclidinium—Osteoarthritis—Methotrexate—multiple sclerosis	0.000517	0.00601	CcSEcCtD
Aclidinium—Infection—Mitoxantrone—multiple sclerosis	0.000506	0.00589	CcSEcCtD
Aclidinium—Eye disorder—Methylprednisolone—multiple sclerosis	0.000505	0.00587	CcSEcCtD
Aclidinium—Tachycardia—Mitoxantrone—multiple sclerosis	0.000497	0.00578	CcSEcCtD
Aclidinium—Vomiting—Cladribine—multiple sclerosis	0.000493	0.00573	CcSEcCtD
Aclidinium—Mediastinal disorder—Methylprednisolone—multiple sclerosis	0.000487	0.00566	CcSEcCtD
Aclidinium—Headache—Cladribine—multiple sclerosis	0.000486	0.00565	CcSEcCtD
Aclidinium—Vision blurred—Prednisolone—multiple sclerosis	0.000483	0.00561	CcSEcCtD
Aclidinium—Eye disorder—Dexamethasone—multiple sclerosis	0.000459	0.00534	CcSEcCtD
Aclidinium—Eye disorder—Betamethasone—multiple sclerosis	0.000459	0.00534	CcSEcCtD
Aclidinium—Diarrhoea—Azathioprine—multiple sclerosis	0.000431	0.00502	CcSEcCtD
Aclidinium—Cough—Triamcinolone—multiple sclerosis	0.000411	0.00478	CcSEcCtD
Aclidinium—Tachycardia—Prednisolone—multiple sclerosis	0.000408	0.00475	CcSEcCtD
Aclidinium—Vomiting—Azathioprine—multiple sclerosis	0.000401	0.00466	CcSEcCtD
Aclidinium—Eye disorder—Prednisone—multiple sclerosis	0.0004	0.00465	CcSEcCtD
Aclidinium—Infestation NOS—Methotrexate—multiple sclerosis	0.000398	0.00463	CcSEcCtD
Aclidinium—Infestation—Methotrexate—multiple sclerosis	0.000398	0.00463	CcSEcCtD
Aclidinium—Headache—Azathioprine—multiple sclerosis	0.000395	0.00459	CcSEcCtD
Aclidinium—Dry mouth—Triamcinolone—multiple sclerosis	0.000392	0.00456	CcSEcCtD
Aclidinium—Infection—Triamcinolone—multiple sclerosis	0.000382	0.00444	CcSEcCtD
Aclidinium—Infection—Methylprednisolone—multiple sclerosis	0.000381	0.00443	CcSEcCtD
Aclidinium—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000376	0.00438	CcSEcCtD
Aclidinium—Tachycardia—Triamcinolone—multiple sclerosis	0.000375	0.00436	CcSEcCtD
Aclidinium—Tachycardia—Methylprednisolone—multiple sclerosis	0.000374	0.00435	CcSEcCtD
Aclidinium—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000353	0.0041	CcSEcCtD
Aclidinium—Vision blurred—Prednisone—multiple sclerosis	0.000351	0.00408	CcSEcCtD
Aclidinium—Urethral disorder—Methotrexate—multiple sclerosis	0.00035	0.00407	CcSEcCtD
Aclidinium—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000349	0.00405	CcSEcCtD
Aclidinium—Infection—Betamethasone—multiple sclerosis	0.000347	0.00403	CcSEcCtD
Aclidinium—Infection—Dexamethasone—multiple sclerosis	0.000347	0.00403	CcSEcCtD
Aclidinium—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000342	0.00398	CcSEcCtD
Aclidinium—Nervous system disorder—Betamethasone—multiple sclerosis	0.000342	0.00398	CcSEcCtD
Aclidinium—Tachycardia—Dexamethasone—multiple sclerosis	0.000341	0.00396	CcSEcCtD
Aclidinium—Tachycardia—Betamethasone—multiple sclerosis	0.000341	0.00396	CcSEcCtD
Aclidinium—Eye disorder—Methotrexate—multiple sclerosis	0.000334	0.00388	CcSEcCtD
Aclidinium—Vomiting—Mitoxantrone—multiple sclerosis	0.000324	0.00377	CcSEcCtD
Aclidinium—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000322	0.00375	CcSEcCtD
Aclidinium—Headache—Mitoxantrone—multiple sclerosis	0.000319	0.00371	CcSEcCtD
Aclidinium—Infection—Prednisone—multiple sclerosis	0.000302	0.00351	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000301	0.0035	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000301	0.0035	CcSEcCtD
Aclidinium—Nervous system disorder—Prednisone—multiple sclerosis	0.000298	0.00346	CcSEcCtD
Aclidinium—Tachycardia—Prednisone—multiple sclerosis	0.000297	0.00345	CcSEcCtD
Aclidinium—Vision blurred—Methotrexate—multiple sclerosis	0.000293	0.00341	CcSEcCtD
Aclidinium—Cough—Methotrexate—multiple sclerosis	0.000272	0.00316	CcSEcCtD
Aclidinium—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000263	0.00305	CcSEcCtD
Aclidinium—Headache—Prednisolone—multiple sclerosis	0.000262	0.00305	CcSEcCtD
Aclidinium—Infection—Methotrexate—multiple sclerosis	0.000252	0.00293	CcSEcCtD
Aclidinium—Nervous system disorder—Methotrexate—multiple sclerosis	0.000249	0.0029	CcSEcCtD
Aclidinium—Vomiting—Triamcinolone—multiple sclerosis	0.000245	0.00284	CcSEcCtD
Aclidinium—Vomiting—Methylprednisolone—multiple sclerosis	0.000244	0.00284	CcSEcCtD
Aclidinium—Headache—Triamcinolone—multiple sclerosis	0.000241	0.0028	CcSEcCtD
Aclidinium—Headache—Methylprednisolone—multiple sclerosis	0.00024	0.00279	CcSEcCtD
Aclidinium—Diarrhoea—Dexamethasone—multiple sclerosis	0.000239	0.00278	CcSEcCtD
Aclidinium—Diarrhoea—Betamethasone—multiple sclerosis	0.000239	0.00278	CcSEcCtD
Aclidinium—Vomiting—Dexamethasone—multiple sclerosis	0.000222	0.00258	CcSEcCtD
Aclidinium—Vomiting—Betamethasone—multiple sclerosis	0.000222	0.00258	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000219	0.00255	CcSEcCtD
Aclidinium—Headache—Dexamethasone—multiple sclerosis	0.000219	0.00254	CcSEcCtD
Aclidinium—Headache—Betamethasone—multiple sclerosis	0.000219	0.00254	CcSEcCtD
Aclidinium—Diarrhoea—Prednisone—multiple sclerosis	0.000208	0.00242	CcSEcCtD
Aclidinium—Vomiting—Prednisone—multiple sclerosis	0.000193	0.00225	CcSEcCtD
Aclidinium—Headache—Prednisone—multiple sclerosis	0.00019	0.00221	CcSEcCtD
Aclidinium—Diarrhoea—Methotrexate—multiple sclerosis	0.000174	0.00202	CcSEcCtD
Aclidinium—Vomiting—Methotrexate—multiple sclerosis	0.000161	0.00188	CcSEcCtD
Aclidinium—Headache—Methotrexate—multiple sclerosis	0.000159	0.00185	CcSEcCtD
Aclidinium—CHRM1—Signaling by GPCR—PTGER4—multiple sclerosis	2.65e-05	0.000834	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—PTGER4—multiple sclerosis	2.64e-05	0.000831	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—CCL5—multiple sclerosis	2.64e-05	0.000831	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—RGS1—multiple sclerosis	2.63e-05	0.000828	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—RGS1—multiple sclerosis	2.62e-05	0.000826	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—CCR5—multiple sclerosis	2.62e-05	0.000825	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—PTGER4—multiple sclerosis	2.61e-05	0.000823	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—RGS1—multiple sclerosis	2.59e-05	0.000818	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—IL2RA—multiple sclerosis	2.58e-05	0.000813	CbGpPWpGaD
Aclidinium—BCHE—Neuronal System—MAPK1—multiple sclerosis	2.57e-05	0.000812	CbGpPWpGaD
Aclidinium—BCHE—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.57e-05	0.000811	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—CXCR3—multiple sclerosis	2.56e-05	0.000805	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—CXCR3—multiple sclerosis	2.55e-05	0.000803	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—CNR1—multiple sclerosis	2.53e-05	0.000796	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—CCL5—multiple sclerosis	2.53e-05	0.000796	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—CXCR3—multiple sclerosis	2.52e-05	0.000795	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—CNR1—multiple sclerosis	2.52e-05	0.000794	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—CCR5—multiple sclerosis	2.51e-05	0.00079	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—CNR1—multiple sclerosis	2.49e-05	0.000786	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—GPR65—multiple sclerosis	2.49e-05	0.000785	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—CCR2—multiple sclerosis	2.49e-05	0.000784	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—GPR65—multiple sclerosis	2.48e-05	0.000783	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—CCR2—multiple sclerosis	2.48e-05	0.000781	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—IL2RA—multiple sclerosis	2.47e-05	0.000778	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—GPR65—multiple sclerosis	2.46e-05	0.000775	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—CCR2—multiple sclerosis	2.45e-05	0.000773	CbGpPWpGaD
Aclidinium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	2.45e-05	0.000771	CbGpPWpGaD
Aclidinium—CHRM1—GPCR ligand binding—POMC—multiple sclerosis	2.44e-05	0.000769	CbGpPWpGaD
Aclidinium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	2.44e-05	0.000769	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—POMC—multiple sclerosis	2.43e-05	0.000767	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—POMC—multiple sclerosis	2.41e-05	0.000759	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CCL3—multiple sclerosis	2.41e-05	0.000759	CbGpPWpGaD
Aclidinium—CHRM2—SIDS Susceptibility Pathways—IL6—multiple sclerosis	2.4e-05	0.000756	CbGpPWpGaD
Aclidinium—CHRM1—GPCR ligand binding—CCL2—multiple sclerosis	2.39e-05	0.000752	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—CCL2—multiple sclerosis	2.38e-05	0.00075	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—CCR5—multiple sclerosis	2.38e-05	0.000749	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—CCL2—multiple sclerosis	2.36e-05	0.000743	CbGpPWpGaD
Aclidinium—BCHE—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.35e-05	0.00074	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—IL2RA—multiple sclerosis	2.34e-05	0.000738	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—PTGER4—multiple sclerosis	2.32e-05	0.000731	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CCL3—multiple sclerosis	2.31e-05	0.000727	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—CNR1—multiple sclerosis	2.29e-05	0.000723	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—CNR1—multiple sclerosis	2.29e-05	0.000721	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—PGR—multiple sclerosis	2.28e-05	0.00072	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CXCL13—multiple sclerosis	2.28e-05	0.000718	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CCR1—multiple sclerosis	2.28e-05	0.000718	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—CCR5—multiple sclerosis	2.28e-05	0.000717	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—CXCL10—multiple sclerosis	2.27e-05	0.000717	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CCR1—multiple sclerosis	2.27e-05	0.000716	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CXCL13—multiple sclerosis	2.27e-05	0.000716	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—CXCL10—multiple sclerosis	2.27e-05	0.000715	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—CNR1—multiple sclerosis	2.26e-05	0.000714	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CCR1—multiple sclerosis	2.25e-05	0.000709	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CXCL13—multiple sclerosis	2.25e-05	0.000709	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—CXCL10—multiple sclerosis	2.25e-05	0.000708	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—IL2RA—multiple sclerosis	2.24e-05	0.000707	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CXCR3—multiple sclerosis	2.24e-05	0.000706	CbGpPWpGaD
Aclidinium—BCHE—Metabolism of proteins—POMC—multiple sclerosis	2.22e-05	0.000701	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—PTGER4—multiple sclerosis	2.22e-05	0.0007	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CD28—multiple sclerosis	2.22e-05	0.000699	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—PGR—multiple sclerosis	2.19e-05	0.000689	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CCR2—multiple sclerosis	2.18e-05	0.000686	CbGpPWpGaD
Aclidinium—BCHE—Metabolism of proteins—CCL2—multiple sclerosis	2.18e-05	0.000686	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CXCR3—multiple sclerosis	2.14e-05	0.000676	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CD28—multiple sclerosis	2.12e-05	0.000669	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CCR2—multiple sclerosis	2.09e-05	0.000657	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—CXCL10—multiple sclerosis	2.07e-05	0.000651	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—CXCL10—multiple sclerosis	2.06e-05	0.000649	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—POMC—multiple sclerosis	2.04e-05	0.000644	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—CXCL10—multiple sclerosis	2.04e-05	0.000643	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CNR1—multiple sclerosis	2.01e-05	0.000634	CbGpPWpGaD
Aclidinium—CHRM1—Circadian rythm related genes—IL6—multiple sclerosis	1.98e-05	0.000625	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—POMC—multiple sclerosis	1.96e-05	0.000617	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—CCL5—multiple sclerosis	1.96e-05	0.000617	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—CCL5—multiple sclerosis	1.95e-05	0.000615	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—CCL5—multiple sclerosis	1.93e-05	0.000609	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CNR1—multiple sclerosis	1.92e-05	0.000607	CbGpPWpGaD
Aclidinium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	1.88e-05	0.000593	CbGpPWpGaD
Aclidinium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	1.87e-05	0.000591	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—POMC—multiple sclerosis	1.86e-05	0.000585	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—CCL2—multiple sclerosis	1.82e-05	0.000573	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CXCL10—multiple sclerosis	1.81e-05	0.00057	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—CCL5—multiple sclerosis	1.78e-05	0.00056	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—POMC—multiple sclerosis	1.78e-05	0.00056	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—CCL5—multiple sclerosis	1.77e-05	0.000559	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—CCR5—multiple sclerosis	1.76e-05	0.000556	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—CCR5—multiple sclerosis	1.76e-05	0.000554	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—CCL5—multiple sclerosis	1.76e-05	0.000553	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—CCR5—multiple sclerosis	1.74e-05	0.000549	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—CCL2—multiple sclerosis	1.74e-05	0.000548	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—IL2RA—multiple sclerosis	1.74e-05	0.000548	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CXCL10—multiple sclerosis	1.73e-05	0.000546	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—IL2RA—multiple sclerosis	1.73e-05	0.000546	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—IL2RA—multiple sclerosis	1.72e-05	0.000541	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—BCHE—multiple sclerosis	1.71e-05	0.000538	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—TYK2—multiple sclerosis	1.65e-05	0.00052	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CCL3—multiple sclerosis	1.62e-05	0.000512	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CCL3—multiple sclerosis	1.62e-05	0.00051	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CCL3—multiple sclerosis	1.6e-05	0.000505	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—CCR5—multiple sclerosis	1.6e-05	0.000505	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—CCR5—multiple sclerosis	1.6e-05	0.000503	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CD86—multiple sclerosis	1.58e-05	0.000499	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—CCR5—multiple sclerosis	1.58e-05	0.000498	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—TYK2—multiple sclerosis	1.58e-05	0.000498	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—IL2RA—multiple sclerosis	1.58e-05	0.000498	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—IL2RA—multiple sclerosis	1.57e-05	0.000496	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—PTGER4—multiple sclerosis	1.56e-05	0.000493	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—IL2RA—multiple sclerosis	1.56e-05	0.000491	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—PTGER4—multiple sclerosis	1.56e-05	0.000491	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CCL5—multiple sclerosis	1.56e-05	0.000491	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—PTGER4—multiple sclerosis	1.54e-05	0.000486	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—PGR—multiple sclerosis	1.54e-05	0.000485	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—PGR—multiple sclerosis	1.53e-05	0.000484	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—PGR—multiple sclerosis	1.52e-05	0.000479	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CD86—multiple sclerosis	1.52e-05	0.000478	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—IL2—multiple sclerosis	1.51e-05	0.000476	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CXCR3—multiple sclerosis	1.51e-05	0.000476	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CXCR3—multiple sclerosis	1.5e-05	0.000474	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CD28—multiple sclerosis	1.5e-05	0.000471	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CCL5—multiple sclerosis	1.49e-05	0.00047	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CD28—multiple sclerosis	1.49e-05	0.00047	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CXCR3—multiple sclerosis	1.49e-05	0.00047	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CD28—multiple sclerosis	1.48e-05	0.000465	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CCR2—multiple sclerosis	1.47e-05	0.000463	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CCR2—multiple sclerosis	1.46e-05	0.000461	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CCR2—multiple sclerosis	1.45e-05	0.000457	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—IL2—multiple sclerosis	1.45e-05	0.000456	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—SPP1—multiple sclerosis	1.44e-05	0.000455	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CCR5—multiple sclerosis	1.4e-05	0.000442	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—IL2RA—multiple sclerosis	1.38e-05	0.000436	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—SPP1—multiple sclerosis	1.38e-05	0.000435	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—POMC—multiple sclerosis	1.38e-05	0.000435	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—POMC—multiple sclerosis	1.37e-05	0.000433	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—IL2—multiple sclerosis	1.37e-05	0.000433	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—POMC—multiple sclerosis	1.36e-05	0.000429	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CNR1—multiple sclerosis	1.36e-05	0.000427	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CNR1—multiple sclerosis	1.35e-05	0.000426	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CCR5—multiple sclerosis	1.34e-05	0.000424	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CNR1—multiple sclerosis	1.34e-05	0.000422	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—APOE—multiple sclerosis	1.33e-05	0.000421	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—IL2RA—multiple sclerosis	1.32e-05	0.000417	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—IL2—multiple sclerosis	1.31e-05	0.000414	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—APOE—multiple sclerosis	1.28e-05	0.000402	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—POMC—multiple sclerosis	1.25e-05	0.000395	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—POMC—multiple sclerosis	1.25e-05	0.000393	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—POMC—multiple sclerosis	1.24e-05	0.00039	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—CCL2—multiple sclerosis	1.23e-05	0.000386	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—APOE—multiple sclerosis	1.22e-05	0.000385	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—CCL2—multiple sclerosis	1.22e-05	0.000385	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CXCL10—multiple sclerosis	1.22e-05	0.000385	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CXCL10—multiple sclerosis	1.22e-05	0.000383	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—CCL2—multiple sclerosis	1.21e-05	0.000381	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CXCL10—multiple sclerosis	1.2e-05	0.00038	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CD80—multiple sclerosis	1.15e-05	0.000364	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—POMC—multiple sclerosis	1.15e-05	0.000361	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—TYK2—multiple sclerosis	1.11e-05	0.000351	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—TYK2—multiple sclerosis	1.11e-05	0.000349	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CD80—multiple sclerosis	1.11e-05	0.000348	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—TYK2—multiple sclerosis	1.1e-05	0.000346	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—POMC—multiple sclerosis	1.1e-05	0.000346	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CCL2—multiple sclerosis	1.07e-05	0.000338	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CD86—multiple sclerosis	1.07e-05	0.000336	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CD86—multiple sclerosis	1.06e-05	0.000335	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CD86—multiple sclerosis	1.05e-05	0.000332	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—POMC—multiple sclerosis	1.05e-05	0.000331	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CCL5—multiple sclerosis	1.05e-05	0.000331	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—MAPK1—multiple sclerosis	1.05e-05	0.000331	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CCL5—multiple sclerosis	1.05e-05	0.00033	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—ALB—multiple sclerosis	1.05e-05	0.000329	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CCL5—multiple sclerosis	1.04e-05	0.000327	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CCL2—multiple sclerosis	1.03e-05	0.000324	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—APOE—multiple sclerosis	1.03e-05	0.000323	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—IL2—multiple sclerosis	1.02e-05	0.000321	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—IL2—multiple sclerosis	1.02e-05	0.00032	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—IL2—multiple sclerosis	1.01e-05	0.000317	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—MAPK1—multiple sclerosis	1.01e-05	0.000317	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—TYK2—multiple sclerosis	9.75e-06	0.000307	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—SPP1—multiple sclerosis	9.73e-06	0.000307	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—SPP1—multiple sclerosis	9.7e-06	0.000306	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—SPP1—multiple sclerosis	9.6e-06	0.000303	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CCR5—multiple sclerosis	9.46e-06	0.000298	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CCR5—multiple sclerosis	9.43e-06	0.000297	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CCR5—multiple sclerosis	9.34e-06	0.000294	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—TYK2—multiple sclerosis	9.33e-06	0.000294	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—IL2RA—multiple sclerosis	9.33e-06	0.000294	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—IL2RA—multiple sclerosis	9.3e-06	0.000293	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—IL2—multiple sclerosis	9.26e-06	0.000292	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—IL2—multiple sclerosis	9.23e-06	0.000291	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—IL2RA—multiple sclerosis	9.21e-06	0.00029	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—IL2—multiple sclerosis	9.14e-06	0.000288	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—POMC—multiple sclerosis	8.82e-06	0.000278	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—APOE—multiple sclerosis	8.61e-06	0.000271	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—APOE—multiple sclerosis	8.58e-06	0.00027	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—APOE—multiple sclerosis	8.5e-06	0.000268	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—IL2—multiple sclerosis	8.11e-06	0.000256	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—IL6—multiple sclerosis	8.07e-06	0.000254	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—ALB—multiple sclerosis	8.04e-06	0.000253	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CD80—multiple sclerosis	7.78e-06	0.000245	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—IL2—multiple sclerosis	7.77e-06	0.000245	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CD80—multiple sclerosis	7.76e-06	0.000245	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—IL6—multiple sclerosis	7.73e-06	0.000244	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CD80—multiple sclerosis	7.68e-06	0.000242	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—MMP9—multiple sclerosis	7.67e-06	0.000242	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—POMC—multiple sclerosis	7.4e-06	0.000233	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—POMC—multiple sclerosis	7.37e-06	0.000232	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—MMP9—multiple sclerosis	7.35e-06	0.000232	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—POMC—multiple sclerosis	7.3e-06	0.00023	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CCL2—multiple sclerosis	7.24e-06	0.000228	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CCL2—multiple sclerosis	7.21e-06	0.000227	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CCL2—multiple sclerosis	7.14e-06	0.000225	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—MAPK1—multiple sclerosis	7.08e-06	0.000223	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—MAPK1—multiple sclerosis	7.06e-06	0.000222	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—MAPK1—multiple sclerosis	6.99e-06	0.00022	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—STAT3—multiple sclerosis	6.82e-06	0.000215	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—TYK2—multiple sclerosis	6.57e-06	0.000207	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—TYK2—multiple sclerosis	6.55e-06	0.000206	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—STAT3—multiple sclerosis	6.53e-06	0.000206	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—TYK2—multiple sclerosis	6.49e-06	0.000204	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—MYC—multiple sclerosis	6.34e-06	0.0002	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—TGFB1—multiple sclerosis	6.33e-06	0.000199	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—MAPK1—multiple sclerosis	6.2e-06	0.000196	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—MYC—multiple sclerosis	6.07e-06	0.000191	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—TGFB1—multiple sclerosis	6.06e-06	0.000191	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—MAPK1—multiple sclerosis	5.94e-06	0.000187	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—IL2—multiple sclerosis	5.47e-06	0.000172	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—IL2—multiple sclerosis	5.45e-06	0.000172	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—IL6—multiple sclerosis	5.44e-06	0.000171	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—IL6—multiple sclerosis	5.42e-06	0.000171	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—IL2—multiple sclerosis	5.4e-06	0.00017	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—IL6—multiple sclerosis	5.37e-06	0.000169	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—MMP9—multiple sclerosis	5.17e-06	0.000163	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—MMP9—multiple sclerosis	5.16e-06	0.000163	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—MMP9—multiple sclerosis	5.11e-06	0.000161	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—IL6—multiple sclerosis	4.77e-06	0.00015	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—STAT3—multiple sclerosis	4.6e-06	0.000145	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—STAT3—multiple sclerosis	4.59e-06	0.000145	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—IL6—multiple sclerosis	4.56e-06	0.000144	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—STAT3—multiple sclerosis	4.54e-06	0.000143	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—MYC—multiple sclerosis	4.28e-06	0.000135	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—TGFB1—multiple sclerosis	4.27e-06	0.000134	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—MYC—multiple sclerosis	4.26e-06	0.000134	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—TGFB1—multiple sclerosis	4.25e-06	0.000134	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—MYC—multiple sclerosis	4.22e-06	0.000133	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—TGFB1—multiple sclerosis	4.21e-06	0.000133	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—MAPK1—multiple sclerosis	4.18e-06	0.000132	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—MAPK1—multiple sclerosis	4.17e-06	0.000131	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—MAPK1—multiple sclerosis	4.13e-06	0.00013	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—IL6—multiple sclerosis	3.21e-06	0.000101	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—IL6—multiple sclerosis	3.2e-06	0.000101	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—IL6—multiple sclerosis	3.17e-06	0.0001	CbGpPWpGaD
